XML 21 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Balance Sheet Information
3 Months Ended
Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
Other Balance Sheet Information

NOTE 5. OTHER BALANCE SHEET INFORMATION

 

Inventory consisted of the following.

 

 

 

As of

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Finished Goods

 

$

30,509

 

 

$

41,206

 

Raw Materials

 

 

390

 

 

 

369

 

Total inventory

 

$

30,899

 

 

$

41,575

 

 

The Company writes-down inventory for any excess or obsolete inventories or when the Company believes the net realizable value of inventories is less than the carrying value. During the three months ended March 31, 2024 and 2023, the Company recorded write-downs of $96 and $66, respectively.

 

Prepaid expenses and other current assets consisted of the following.

 

 

 

As of

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Prepaid expenses

 

$

8,205

 

 

$

7,144

 

Other current assets

 

 

5,804

 

 

 

2,215

 

Total prepaid expenses and other current assets

 

$

14,009

 

 

$

9,359

 

 

Property and equipment, net consisted of the following.

 

 

 

As of

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Computer hardware

 

$

2,320

 

 

$

2,242

 

Leasehold improvements

 

 

716

 

 

 

717

 

Warehouse and other equipment

 

 

767

 

 

 

748

 

Furniture and fixtures

 

 

146

 

 

 

146

 

Property and equipment

 

 

3,949

 

 

 

3,853

 

Less: Accumulated depreciation

 

 

(2,635

)

 

 

(2,453

)

Total property and equipment, net

 

$

1,314

 

 

$

1,400

 

 

Depreciation and amortization expense on all property, plant and equipment was $182 and $203 during the three months ended March 31, 2024 and 2023, respectively.

 

Intangible assets, net consisted of the following.

 

 

 

As of

 

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

Gross

 

 

Accumulated Amortization

 

 

Net

 

 

Gross

 

 

Accumulated Amortization

 

 

Net

 

Customer relationships

 

$

22,990

 

 

$

(4,557

)

 

$

18,433

 

 

$

22,990

 

 

$

(4,001

)

 

$

18,989

 

Developed technology

 

 

10,600

 

 

 

(3,279

)

 

 

7,321

 

 

 

10,600

 

 

 

(2,911

)

 

 

7,689

 

Trade name

 

 

900

 

 

 

(374

)

 

 

526

 

 

 

900

 

 

 

(329

)

 

 

571

 

Total intangible assets, net

 

$

34,490

 

 

$

(8,210

)

 

$

26,280

 

 

$

34,490

 

 

$

(7,241

)

 

$

27,249

 

 

Amortization expense on all intangible assets was $969 and $969 for the three months ended March 31, 2024 and 2023, respectively. Total future amortization for finite-lived intangible assets is estimated as follows.

 

 

 

Amortization Expense

 

2024 - Remaining

 

$

2,905

 

2025

 

 

3,873

 

2026

 

 

3,873

 

2027

 

 

3,734

 

2028

 

 

3,693

 

Thereafter

 

 

8,202

 

Total

 

$

26,280

 

 

Other long-term assets consisted of the following.

 

 

 

As of

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Capitalized software costs, net

 

$

5,852

 

 

$

5,632

 

Investment in non-affiliate

 

 

2,250

 

 

 

2,250

 

Operating lease - ROU asset, net

 

 

2,175

 

 

 

2,550

 

Other long-term assets

 

 

2,045

 

 

 

1,816

 

Total other long-term assets

 

$

12,322

 

 

$

12,248

 

 

Amortization expense on capitalized research and development costs was $350 and $82 for the three months ended March 31, 2024 and 2023, respectively, which is primarily related to capitalized software costs and was recorded in research and development expenses on the Consolidated Statements of Operations and Comprehensive Loss.

 

In December 2023, the Company invested $2,250 in a non-affiliated, privately held entity, under a Simple Agreement for Future Equity ("SAFE") agreement. The non-affiliated entity provides support and consultation for consumers looking to manage and upgrade the technology within their home. The Company’s investment in the SAFE is recorded using the cost method of accounting and included under other long-term assets on the Consolidated Balance Sheets, as it is not readily convertible into cash. If the Company identifies factors that may be indicative of impairment the Company will review the investment for impairment. For the three months ended March 31, 2024 and the year ended December 31, 2023, the Company did not identify any factors indicative of impairment.

 

Accrued expenses and other current liabilities consisted of the following.

 

 

As of

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Accrued expenses

 

$

6,697

 

 

$

6,674

 

Accrued compensation costs

 

 

4,206

 

 

 

10,272

 

Warranty allowance

 

 

1,570

 

 

 

2,215

 

Other

 

 

8,738

 

 

 

5,815

 

Total accrued expenses and other current liabilities

 

$

21,211

 

 

$

24,976